<code id='275802A5EA'></code><style id='275802A5EA'></style>
      • <acronym id='275802A5EA'></acronym>
      <center id='275802A5EA'><center id='275802A5EA'><tfoot id='275802A5EA'></tfoot></center><abbr id='275802A5EA'><dir id='275802A5EA'><tfoot id='275802A5EA'></tfoot><noframes id='275802A5EA'>
      • <optgroup id='275802A5EA'><strike id='275802A5EA'><sup id='275802A5EA'></sup></strike><code id='275802A5EA'></code></optgroup>
        5. <b id='275802A5EA'><label id='275802A5EA'><select id='275802A5EA'><dt id='275802A5EA'><span id='275802A5EA'></span></dt></select></label></b><u id='275802A5EA'></u>
          <i id='275802A5EA'><strike id='275802A5EA'><tt id='275802A5EA'><pre id='275802A5EA'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / fashion / focus      
           
     
           
      
          focus 
           
      
           
      
           
       2025-09-27 11:46:09 
   
      
           
      
           
                        
          focus  
          
                                   
                 
                                      author：explore   
                                        
                                      
                                      Page View：17
                                  
                                    
          
                                   
          Lessons Learned
          Molly Ferguson for STAT
          Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column. 
          Who we talked to:
          advertisement
          Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Maisha Meds is a PBM, but don't call it that
                                
                            
          Next article：  
                                      
                                          Moonlake's readout produced a cash windfall. Risks remain
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles